Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1987 Apr;62(4):357–361. doi: 10.1136/adc.62.4.357

Serum IgG antibodies in patients with cystic fibrosis with early Pseudomonas aeruginosa infection.

M M Brett, A T Ghoneim, J M Littlewood
PMCID: PMC1778335  PMID: 3109335

Abstract

Serum IgG antibodies to Pseudomonas aeruginosa surface antigens were measured by enzyme linked immunosorbent assay in all patients with cystic fibrosis from whom P. aeruginosa was isolated for the first time during a study period of 18 months. In 15 patients the titre of serum IgG antibodies was greater than control values before or at the time of the first bacteriological isolation of P. aeruginosa. The presence of serum antibodies specific to P. aeruginosa suggests exposure to infection by that organism for some months before its isolation in significant numbers from the respiratory tract. In the other two patients serum titres were within the control range before isolation of P. aeruginosa but had increased to above the control range within the next month. Longitudinal studies on the entire group of patients showed further increases in titre concurrently with further isolations of P. aeruginosa. These results suggest that this assay may be an indicator of the beginning of pulmonary infection by P. aeruginosa and may prove to be a sensitive monitor of the progress of infection, and response to treatment, during the first months of infection by that organism.

Full text

PDF
357

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Borowski R. S., Stock L. M., Schiller N. L. Development of an enzyme-linked immunosorbent assay for studying Pseudomonas aeruginosa cell surface antigens. J Clin Microbiol. 1984 Jun;19(6):736–741. doi: 10.1128/jcm.19.6.736-741.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brett M. M., Ghoneim A. T., Littlewood J. M., Losowsky M. S. Development of enzyme linked immunosorbent assay (ELISA) to detect antibodies to Pseudomonas aeruginosa cell surface antigens in sera of patients with cystic fibrosis. J Clin Pathol. 1986 Oct;39(10):1124–1129. doi: 10.1136/jcp.39.10.1124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brett M. M., Ghoneim A. T., Littlewood J. M. Serum antibodies to Pseudomonas aeruginosa in cystic fibrosis. Arch Dis Child. 1986 Nov;61(11):1114–1120. doi: 10.1136/adc.61.11.1114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chrispin A. R., Norman A. P. The systematic evaluation of the chest radiograph in cystic fibrosis. Pediatr Radiol. 1974;2(2):101–105. doi: 10.1007/BF01314939. [DOI] [PubMed] [Google Scholar]
  5. Cost K. M., West C. S., Brinson D., Polk H. C., Jr Measurement of human antibody activity against Escherichia coli and Pseudomonas aeruginosa using formalin treated whole organisms in an ELISA technique. J Immunoassay. 1985;6(1-2):23–43. doi: 10.1080/01971528508063019. [DOI] [PubMed] [Google Scholar]
  6. Czerkinsky C., Rees A. S., Bergmeier L. A., Challacombe S. J. The detection and specificity of class specific antibodies to whole bacterial cells using a solid phase radioimmunoassay. Clin Exp Immunol. 1983 Jul;53(1):192–200. [PMC free article] [PubMed] [Google Scholar]
  7. Danneman P. J., Michael J. G. Reaginic antibody production to protein antigens of Escherichia coli and Pseudomonas aeruginosa by mice. Infect Immun. 1976 Sep;14(3):694–702. doi: 10.1128/iai.14.3.694-702.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. GIBSON L. E., COOKE R. E. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics. 1959 Mar;23(3):545–549. [PubMed] [Google Scholar]
  9. Hancock R. E., Mouat E. C., Speert D. P. Quantitation and identification of antibodies to outer-membrane proteins of Pseudomonas aeruginosa in sera of patients with cystic fibrosis. J Infect Dis. 1984 Feb;149(2):220–226. doi: 10.1093/infdis/149.2.220. [DOI] [PubMed] [Google Scholar]
  10. Hancock R. E., Wieczorek A. A., Mutharia L. M., Poole K. Monoclonal antibodies against Pseudomonas aeruginosa outer membrane antigens: isolation and characterization. Infect Immun. 1982 Jul;37(1):166–171. doi: 10.1128/iai.37.1.166-171.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hedstrom R. C., Pavlovskis O. R., Galloway D. R. Antibody response of infected mice to outer membrane proteins of Pseudomonas aeruginosa. Infect Immun. 1984 Jan;43(1):49–53. doi: 10.1128/iai.43.1.49-53.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hoiby N., Flensborg E. W., Beck B., Friis B., Jacobsen S. V., Jacobsen L. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. Scand J Respir Dis. 1977 Apr;58(2):65–79. [PubMed] [Google Scholar]
  13. Hoiby N. Pseudomonas aeruginosa infection in cystic fibrosis. Relationship between mucoid strains of Pseudomonas aeruginosa and the humoral immune response. Acta Pathol Microbiol Scand B Microbiol Immunol. 1974 Aug;82(4):551–558. [PubMed] [Google Scholar]
  14. Høiby N., Wiik A. Antibacterial precipitins and autoantibodies in serum of patients with cystic fibrosis. Scand J Respir Dis. 1975 May;56(1):38–46. [PubMed] [Google Scholar]
  15. Kohler R. B., Wheat L. J., White A. Rapid diagnosis of Pseudomonas aeruginosa urinary tract infections by radioimmunoassay. J Clin Microbiol. 1979 Feb;9(2):253–258. doi: 10.1128/jcm.9.2.253-258.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lam J. S., Mutharia L. M., Hancock R. E., Høiby N., Lam K., Baek L., Costerton J. W. Immunogenicity of Pseudomonas aeruginosa outer membrane antigens examined by crossed immunoelectrophoresis. Infect Immun. 1983 Oct;42(1):88–98. doi: 10.1128/iai.42.1.88-98.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mearns M. B., Hunt G. H., Rushworth R. Bacterial flora of respiratory tract in patients with cystic fibrosis, 1950-71. Arch Dis Child. 1972 Dec;47(256):902–907. doi: 10.1136/adc.47.256.902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mutharia L. M., Nicas T. I., Hancock R. E. Outer membrane proteins of Pseudomonas aeruginosa serotype strains. J Infect Dis. 1982 Dec;146(6):770–779. doi: 10.1093/infdis/146.6.770. [DOI] [PubMed] [Google Scholar]
  19. Peters K., Richards F. M. Chemical cross-linking: reagents and problems in studies of membrane structure. Annu Rev Biochem. 1977;46:523–551. doi: 10.1146/annurev.bi.46.070177.002515. [DOI] [PubMed] [Google Scholar]
  20. Pier G. B. Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: current status of the host-bacterium interaction. J Infect Dis. 1985 Apr;151(4):575–580. doi: 10.1093/infdis/151.4.575. [DOI] [PubMed] [Google Scholar]
  21. SHWACHMAN H., KULCZYCKI L. L. Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period. AMA J Dis Child. 1958 Jul;96(1):6–15. doi: 10.1001/archpedi.1958.02060060008002. [DOI] [PubMed] [Google Scholar]
  22. Thunberg A. L., Kindt T. J. Sequence variability of rabbit antibody light chains. Familial occurrence of n-terminal sequence differences between b4 and b9 light chains. Scand J Immunol. 1975;4(2):197–201. doi: 10.1111/j.1365-3083.1975.tb02617.x. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES